Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.81)
# 768
Out of 5,182 analysts
497
Total ratings
43.56%
Success rate
10.84%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Maintains: Buy | $130 → $150 | $93.69 | +60.10% | 7 | Apr 27, 2026 | |
| EVAX Evaxion | Reiterates: Buy | $16 | $4.12 | +288.35% | 16 | Apr 24, 2026 | |
| ACTU Actuate Therapeutics | Reiterates: Buy | $15 | $2.93 | +411.95% | 6 | Apr 22, 2026 | |
| NUVL Nuvalent | Reiterates: Buy | $155 | $102.60 | +51.07% | 6 | Apr 21, 2026 | |
| VOR Vor Biopharma | Maintains: Buy | $32 → $31 | $14.50 | +113.87% | 17 | Apr 15, 2026 | |
| EDAP EDAP TMS | Maintains: Buy | $14 → $10 | $3.22 | +210.87% | 15 | Apr 9, 2026 | |
| RNXT RenovoRx | Reiterates: Buy | $3 | $0.84 | +257.14% | 4 | Apr 8, 2026 | |
| IPHA Innate Pharma | Reiterates: Buy | $5 | $1.42 | +252.11% | 19 | Apr 7, 2026 | |
| PGEN Precigen | Maintains: Buy | $9 → $10 | $3.98 | +151.26% | 15 | Mar 26, 2026 | |
| CORT Corcept Therapeutics | Maintains: Buy | $67 → $60 | $46.69 | +28.51% | 30 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.65 | +506.06% | 23 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.74 | +303.46% | 12 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $52 | $23.73 | +119.13% | 10 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.5 → $10 | $7.12 | +40.45% | 9 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.55 | +287.10% | 16 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.58 | +153.16% | 16 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $130 | $84.13 | +54.52% | 9 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $64 | $35.36 | +81.00% | 19 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $18 | $5.95 | +202.52% | 14 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $10.75 | +179.07% | 16 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.71 | +47.87% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.64 | - | 17 | Dec 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $4.89 | +63.60% | 15 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $45 | $14.77 | +204.67% | 14 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $36 | $16.68 | +115.89% | 20 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $77 → $94 | $122.60 | -23.33% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $5.50 | +136.36% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $4.11 | +21.80% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $50 | $2.94 | +1,600.68% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $7.20 | +205.56% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.81 | +268.19% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.40 | +2,639.73% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $2.21 | +578.73% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.78 | +286.30% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.91 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.92 | +82.29% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $4.73 | +597.67% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $5.28 | +2,267.42% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.37 | +226.41% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $0.57 | +3,406.31% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $7.43 | +21.13% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.58 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.73 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.03 | +2,328.13% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.42 | +46.20% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $2.56 | +4,587.50% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,250 → $1,000 | $4.58 | +21,734.06% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $21.72 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $15.66 | -61.69% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.43 | +949.02% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $5.43 | +507.73% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $9.78 | -2.81% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.04 | +1,346,053.85% | 1 | Mar 5, 2020 |
Mirum Pharmaceuticals
Apr 27, 2026
Maintains: Buy
Price Target: $130 → $150
Current: $93.69
Upside: +60.10%
Evaxion
Apr 24, 2026
Reiterates: Buy
Price Target: $16
Current: $4.12
Upside: +288.35%
Actuate Therapeutics
Apr 22, 2026
Reiterates: Buy
Price Target: $15
Current: $2.93
Upside: +411.95%
Nuvalent
Apr 21, 2026
Reiterates: Buy
Price Target: $155
Current: $102.60
Upside: +51.07%
Vor Biopharma
Apr 15, 2026
Maintains: Buy
Price Target: $32 → $31
Current: $14.50
Upside: +113.87%
EDAP TMS
Apr 9, 2026
Maintains: Buy
Price Target: $14 → $10
Current: $3.22
Upside: +210.87%
RenovoRx
Apr 8, 2026
Reiterates: Buy
Price Target: $3
Current: $0.84
Upside: +257.14%
Innate Pharma
Apr 7, 2026
Reiterates: Buy
Price Target: $5
Current: $1.42
Upside: +252.11%
Precigen
Mar 26, 2026
Maintains: Buy
Price Target: $9 → $10
Current: $3.98
Upside: +151.26%
Corcept Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $67 → $60
Current: $46.69
Upside: +28.51%
Mar 25, 2026
Maintains: Buy
Price Target: $7 → $10
Current: $1.65
Upside: +506.06%
Mar 24, 2026
Reiterates: Buy
Price Target: $7
Current: $1.74
Upside: +303.46%
Mar 20, 2026
Maintains: Buy
Price Target: $37 → $52
Current: $23.73
Upside: +119.13%
Mar 19, 2026
Maintains: Buy
Price Target: $4.5 → $10
Current: $7.12
Upside: +40.45%
Mar 13, 2026
Reiterates: Buy
Price Target: $6
Current: $1.55
Upside: +287.10%
Mar 10, 2026
Reiterates: Buy
Price Target: $4
Current: $1.58
Upside: +153.16%
Mar 9, 2026
Maintains: Buy
Price Target: $47 → $130
Current: $84.13
Upside: +54.52%
Feb 27, 2026
Maintains: Buy
Price Target: $60 → $64
Current: $35.36
Upside: +81.00%
Jan 26, 2026
Maintains: Buy
Price Target: $25 → $18
Current: $5.95
Upside: +202.52%
Jan 9, 2026
Reiterates: Buy
Price Target: $30
Current: $10.75
Upside: +179.07%
Jan 7, 2026
Initiates: Buy
Price Target: $4
Current: $2.71
Upside: +47.87%
Dec 31, 2025
Downgrades: Neutral
Price Target: n/a
Current: $11.64
Upside: -
Dec 18, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $4.89
Upside: +63.60%
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $14.77
Upside: +204.67%
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $16.68
Upside: +115.89%
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $122.60
Upside: -23.33%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $5.50
Upside: +136.36%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $4.11
Upside: +21.80%
Nov 4, 2025
Assumes: Buy
Price Target: $50
Current: $2.94
Upside: +1,600.68%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $7.20
Upside: +205.56%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.81
Upside: +268.19%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $0.40
Upside: +2,639.73%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $2.21
Upside: +578.73%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.78
Upside: +286.30%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.91
Upside: -
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.92
Upside: +82.29%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $4.73
Upside: +597.67%
Nov 21, 2024
Reiterates: Buy
Price Target: $125
Current: $5.28
Upside: +2,267.42%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $3.37
Upside: +226.41%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $0.57
Upside: +3,406.31%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $7.43
Upside: +21.13%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.58
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.73
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.03
Upside: +2,328.13%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $3.42
Upside: +46.20%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $2.56
Upside: +4,587.50%
Aug 10, 2022
Maintains: Buy
Price Target: $1,250 → $1,000
Current: $4.58
Upside: +21,734.06%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $21.72
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $15.66
Upside: -61.69%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.43
Upside: +949.02%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $5.43
Upside: +507.73%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $9.78
Upside: -2.81%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.04
Upside: +1,346,053.85%